Pathogenesis of IgA nephropathy

Nature Reviews Nephrology

Volumn 8, Issue 5, 2012, Pages 275-283

  Lai, Kar Neng ^a  

^a HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN G ANTIBODY; TOLL LIKE RECEPTOR;

ANTIGEN ANTIBODY COMPLEX; B LYMPHOCYTE; CYTOKINE PRODUCTION; DISEASE COURSE; GENETIC ASSOCIATION; GLYCOSYLATION; HEREDITY; HUMAN; IMMUNOCHEMISTRY; IMMUNOGLOBULIN A NEPHROPATHY; MEDICAL LITERATURE; MESANGIUM; NONHUMAN; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TONSILLITIS;

ANTIGEN-ANTIBODY COMPLEX; B-LYMPHOCYTES; GENETIC LINKAGE; GENOME-WIDE ASSOCIATION STUDY; GLOMERULONEPHRITIS, IGA; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN A; KIDNEY GLOMERULUS; MESANGIAL CELLS; RENIN-ANGIOTENSIN SYSTEM; T-LYMPHOCYTES;

EID: 84860275665     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2012.58     Document Type: Review

References (103)

1. Sanders, J. T. & Wyatt, R. J. IgA nephropathy and Henoch-Schönlein purpura nephritis. Curr. Opin. Pediatr. 20, 163-170 (2008). (Pubitemid 351365706)
2. Roufosse, C. A. & Cook, H. T. Pathological predictors of prognosis in immunoglobulin A nephropathy: a review. Curr. Opin. Nephrol. Hypertens. 18, 212-219 (2009).
3. Schena, F. P. A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am. J. Med. 89, 209-215 (1990). (Pubitemid 20254446)
4. Nair, R. & Walker, P. D. Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA? Kidney Int. 69, 1455-1458 (2006).
5. Suzuki, H. et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J. Clin. Invest. 119, 1668-1677 (2009).
6. Suzuki, Y. et al. Pathological role of tonsillar B cells in IgA nephropathy. Clin. Dev. Immunol. 2011, 639074 (2011).
7. Mestecky, J. & McGhee, J. R. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol. 40, 153-245 (1987). (Pubitemid 17099007)
8. Hiki, Y. et al. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int. 59, 1077-1085 (2001). (Pubitemid 32206870)
9. Tomana, M. et al. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int. 52, 509-516 (1997). (Pubitemid 27359597)
10. Tomana, M. et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J. Clin. Invest. 104, 73-81 (1999). (Pubitemid 29534347)
11. Ju, T. & Cummings, R. D. A unique molecular chaperone Cosmc required for activity of the mammalian core 1 β 3-galactosyltransferase. Proc. Natl Acad. Sci. USA 99, 16613-16618 (2002). (Pubitemid 36034021)
12. Raska, M. et al. Identification and characterization of CMP-NeuAc:GalNAc-IgA1 α2,6-sialyltransferase in IgA1-producing cells. J. Mol. Biol. 369, 69-78 (2007). (Pubitemid 46635435)
13. Suzuki, H. et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J. Clin. Invest. 118, 629-639 (2008). (Pubitemid 351206552)
14. Li, G. S., Zhang, H., Lv, J. C., Shen, Y. & Wang, H. Y. Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy. Kidney Int. 71, 448-453 (2007).
15. Pirulli, D. et al. Genetic variant of C1GalT1 contributes to the susceptibility to IgA nephropathy. J. Nephrol. 22, 152-159 (2009).
16. Zhu, L. et al. Interaction between variants of two glycosyltransferase genes in IgA nephropathy Kidney Int. 76, 190-198 (2009).
17. Buck, K. S. et al. B-cell O-galactosyltransferase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy. Kidney Int. 73, 1128-1136 (2008). (Pubitemid 351620426)
18. Smith, A. C., de Wolff, J. F., Molyneux, K., Feehally, J. & Barratt, J. O-glycosylation of serum IgD in IgA nephropathy. J. Am. Soc. Nephrol. 17, 1192-1199 (2006).
19. Leung, J. C., Tang, S. C., Lam, M. F., Chan, T. M. & Lai, K. N. Charge-dependent binding of polymeric IgA1 to human mesangial cells in IgA nephropathy. Kidney Int. 59, 277-285 (2001). (Pubitemid 32055236)
20. Leung, J. C., Poon, P. Y & Lai, K. N. Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy? J. Lab. Clin. Med. 133, 152-160 (1999). (Pubitemid 29073239)
21. Lai, K. N., Ho, R. T., Lai, C. K., Chan, C. H. & Li, P. K. Increase of both circulating Th1 and Th2 T lymphocyte subsets in IgA nephropathy. Clin. Exp. Immunol. 96, 116-121 (1994). (Pubitemid 24213808)
22. Ebihara, I. et al. Th2 predominance at the single-cell level in patients with IgA nephropathy Nephrol. Dial. Transplant. 16, 1783-1789 (2001). (Pubitemid 32821409)
23. Lai, K. N. et al. CD4-positive cells from patients with IgA nephropathy demonstrate increased mRNA of cytokines that induce the IgA switch and differentiation. J. Pathol. 174, 13-22 (1994). (Pubitemid 24314860)
24. Lai, K. N., Ho, R. T., Leung, J. C., Lai, F M. & Li, P. K. Increased mRNA encoding for transforming factor-β in CD4+ cells from patients with IgA nephropathy. Kidney Int. 46, 862-868 (1994).
25. Toyabe, S., Harada, W. & Uchiyama, M. Oligoclonally expanding γδ T lymphocytes induce IgA switching in IgA nephropathy. Clin. Exp. Immunol. 124, 110-117 (2001). (Pubitemid 32476940)
26. Lai, K. N. et al. Characteristics of polymeric a;-IgA binding to leukocytes in IgA nephropathy. J. Am. Soc. Nephrol. 13, 2309-2319 (2002). (Pubitemid 34925241)
27. Yu, H. H. et al. Genetics and immunopathogenesis of IgA nephropathy. Clin. Rev. Allergy Immunol. 41, 198-213 (2011).
28. van den Wall Bake, A. W. et al. The bone marrow as production site of the IgA deposited in the kidneys of patients with IgA nephropathy. Clin. Exp. Immunol. 72, 321-325 (1988).
29. van den Wall Bake, A. W. et al. Elevated production of polymeric and monomeric IgA1 by the bone marrow in IgA nephropathy. Kidney Int. 35, 1400-1404 (1989).
30. Harper, S. J. et al. Increased immunoglobulin A and immunoglobulin A1 cells in bone marrow trephine biopsy specimens in immunoglobulin A nephropathy. Am. J. Kidney Dis. 24, 888-892 (1994). (Pubitemid 24380457)
31. Smith, A. C., Molyneux, K., Feehally, J. & Barratt, J. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. J. Am. Soc. Nephrol. 17, 3520-3528 (2006). (Pubitemid 44865295)
32. Oortwijn, B. D. et al. A pathogenic role for secretory IgA in IgA nephropathy. Kidney Int. 69, 1131-1138 (2006).
33. Layward, L., Allen, A. C., Harper, S. J., Hattersley, J. M. & Feehally, J. Increased and prolonged production of specific polymeric IgA after systemic immunization with tetanus toxoid in IgA nephropathy. Clin. Exp. Immunol. 88, 394-398 (1992).
34. Suzuki, H. et al. Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells. Kidney Int. 72, 319-327 (2007). (Pubitemid 47172373)
35. Suzuki, Y & Tomino, Y The mucosa-bone-marrow axis in IgA nephropathy. Contrib. Nephrol. 157, 70-79 (2007).
36. Béné, M. C., Hurault De Ligny, B., Kessler, M. & Faure, G. C. Confirmation of tonsillar anomalies in IgA nephropathy: a multicenter study. Nephron 58, 425-428 (1991).
37. Kusakari, C. et al. Immunopathological features of palatine tonsil characteristic of IgA nephropathy: IgA1 localization in follicular dendritic cells. Clin. Exp. Immunol. 95, 42-48 (1994). (Pubitemid 24207101)
38. Harper, S. J. et al. Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathy. Kidney Int. 45, 836-844 (1994). (Pubitemid 24094497)
39. Qin, W. et al. External suppression causes the low expression of the Cosmc gene in IgA nephropathy. Nephrol. Dial. Transplant 23, 1608-1614 (2008). (Pubitemid 351767729)
40. Coppo, R. et al. Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin A nephropathy Clin. Exp. Immunol. 159, 73-81 (2010).
41. Coppo, R., Amore, A., Peruzzi, L., Vergano, L. & Camilla, R. Innate immunity and IgA nephropathy J. Nephrol. 23, 626-632 (2010).
42. Suzuki, H. et al. Toll-like receptor 9 affects severity of IgA nephropathy. J. Am. Soc. Nephrol. 19, 2384-2395 (2008).
43. Monteiro, R. C., Cooper, M. D. & Kubagawa, H. Molecular heterogeneity of Fc alpha receptors detected by receptor-specific monoclonal antibodies. J. Immunol. 148, 1764-1770 (1992).
44. Morton, H. C., van Egmond, M. & van de Winkel, J. G. Structure and function of human IgA Fc receptors (FcαR). Crit. Rev. Immunol. 16, 423-440 (1996). (Pubitemid 26419111)
45. Reterink, T. J. et al. Size-dependent effect of IgA on the IgA Fc receptor (CD89). Eur. J. Immunol. 27, 2219-2224 (1997). (Pubitemid 27404303)
46. Monteiro, R. C., Kubagawa, H. & Cooper, M. D. Cellular distribution, regulation, and biochemical nature of an Fc alpha receptor in humans. J. Exp. Med. 171, 597-613 (1990). (Pubitemid 20088968)
47. Grossetête, B. et al. Down-regulation of Fcα receptors on blood cells of IgA nephropathy patients: evidence for a negative regulatory role of serum IgA. Kidney Int. 53, 1321-1335 (1998) (Pubitemid 28316894)
48. Gómez-Guerrero, C., González, E. & Egido, J. Evidence for a specific IgA receptor in rat and human mesangial cells. J. Immunol. 151, 7172-7181 (1993). (Pubitemid 24001091)
49. Mostov, K. E., Friedlander, M. & Blobel, G. The receptor for transepithelial transport of IgA and IgM contains multiple immunoglobulin-like domains. Nature 308, 37-43 (1984). (Pubitemid 14130929)
50. Moura, I. C. et al. The glomerular response to IgA deposition in IgA nephropathy. Semin. Nephrol. 28, 88-95 (2008).
51. Diven, S. C. et al. IgA induced activation of human mesangial cells: independent of FcalphaR1 (CD 89). Kidney Int 54, 837-847 (1998). (Pubitemid 28397401)
52. Leung, J. C., Tsang, A. W., Chan, D. T. & Lai, K. N. Absence of CD89, polymeric immunoglobulin receptor, and asialoglycoprotein receptor on human mesangial cells. J. Am. Soc. Nephrol. 11, 241-249 (2000). (Pubitemid 30064847)
53. Vuong, M. T. et al. Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy. Kidney Int. 78, 1281-1287 (2010).
54. Stockert, R. J. The asialoglycoprotein receptor: relationships between structure, function, and expression. Physiol. Rev. 75, 591-609 (1995).
55. Pacifico, F. et al. Differential expression of the asialoglycoprotein receptor in discrete brain areas, in kidney and thyroid. Biochem. Biophys. Res. Commun. 210, 138-144 (1995).
56. Park, J. H., Cho, E. W., Shin, S. Y., Lee, Y. J. & Kim, K. L. Detection of the asialoglycoprotein receptor on cell lines of extrahepatic origin. Biochem. Biophys. Res. Commun. 244, 304-311 (1998) (Pubitemid 28419943)
57. Gómez-Guerrero, C., Duque, N. & Egido, J. Mesangial cells possess an asialoglycoprotein receptor with affinity for human mmunoglobulin A. J. Am. Soc. Nephrol. 9, 568-576 (1998). (Pubitemid 28186044)
58. Piskurich, J. F. et al. Transcriptional regulation of the human polymeric immunoglobulin receptor gene by interferon-γ. Mol. Immunol. 34, 75-91 (1997). (Pubitemid 27244537)
59. Krajci, P. et al. Molecular cloning of the human transmembrane secretory component (poly-Ig receptor) and its mRNA expression in human tissues. Biochem. Biophys. Res. Commun. 158, 783-789 (1989). (Pubitemid 19075992)
60. Moura, I. C. et al. Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J. Exp. Med. 194, 417-425 (2001). (Pubitemid 32835038)
61. Moura, I. C. et al. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J. Am. Soc. Nephrol. 15, 622-634 (2004). (Pubitemid 38294792)
62. McDonald, K. J., Cameron, A. J., Allen, J. M. & Jardine, A. G. Expression of Fc α/μ receptor by human mesangial cells: a candidate receptor for mmune complex deposition in IgA nephropathy. Biochem. Biophys. Res. Commun. 290, 438-442 (2002). (Pubitemid 34694519)
63. Chan, L. Y., Leung, J. C., Tsang, A. W., Tang, S. C. & Lai, K. N. Activation of tubular epithelial cells by mesangial-derived TNF-α: glomerulotubular communication in IgA nephropathy. Kidney Int 67, 602-612 (2005). (Pubitemid 40139851)
64. Lai, K. N. et al. Activation of podocytes by mesangial-derived TNF-α: glomerulo-podocytic communication in IgA nephropathy. Am. J. Physiol. Renal Physiol. 294, F945-F955 (2008).
65. Lavigne, K. A. et al. Familial IgA nephropathy in southeastern Kentucky. Clin. Nephrol. 73, 115-121 (2010).
66. Sissons, J. G. et al. Isolated glomerulonephritis with mesangial IgA deposits. Br. Med. J. 3, 611-614 (1975).
67. Johnston, P. A., Brown, J. S., Braumholtz, D. A. & Davison, A. M. Clinico-pathological correlations and long-term follow-up of 253 United Kingdom patients with IgA nephropathy. A report from the MRC Glomerulonephritis Registry. Q. J. Med. 84, 619-627 (1992). (Pubitemid 23007764)
68. Rambausek, M., Hartz, G., Waldherr, R., Andrassy, K. & Ritz, E. Familial glomerulonephritis. Pediatr. Nephrol. 1, 416-418 (1987). (Pubitemid 18016638)
69. Schena, F P., Scivittaro, V. & Ranieri, E. IgA nephropathy: pros and cons for a familial disease. Contrib. Nephrol. 104, 36-45 (1993).
70. Scolari, F et al. Familial clustering of IgA nephropathy: further evidence in an Italian population. Am. J. Kidney Dis. 33, 857-865 (1999). (Pubitemid 29214681)
71. Levy, M. Familial cases of Berger's disease and anaphylactoid purpura: more frequent than previously thought. Am. J. Med. 87, 246-248 (1989).
72. Tam, K. Y. et al. Macromolecular IgA1 taken from patients with familial IgA nephropathy or their asymptomatic relatives have higher reactivity to mesangial cells in vitro. Kidney Int 75, 1330-1339 (2009).
73. Izzi, C. et al. Familial aggregation of primary glomerulonephritis in an Italian population isolate: Valtrompia study. Kidney Int 69, 1033-1040 (2006). (Pubitemid 43372178)
74. Julian, B. A. et al. Familial IgA nephropathy. Evidence of an inherited mechanism of disease. N. Engl. J. Med. 312, 202-208 (1985). (Pubitemid 15115153)
75. Schena, F P. et al. Increased risk of end-stage renal disease in familial IgA nephropathy. J. Am. Soc. Nephrol. 13, 453-460 (2002). (Pubitemid 34106288)
76. Tam, K. Y et al. In vitro enhanced chemotaxis of CD25+ mononuclear cells in patients with familial IgAN through glomerulotubular interactions. Am. J. Physiol. Renal Physiol. 299, F359-F368 (2010).
77. Julian, B. A., Woodford, S. Y., Baehler, R. W., McMorrow, R. G. & Wyatt, R. J. Familial clustering and immunogenetic aspects of IgA nephropathy. Am. J. Kidney Dis. 12, 366-370 (1988).
78. Izzi, C. et al. IgA nephropathy: the presence of familial disease does not confer an increased risk for progression. Am. J. Kidney Dis. 47, 761-769 (2006).
79. Frascá, G. M. et al. Thin basement membrane disease in patients with familial IgA nephropathy. J. Nephrol. 17, 778-785 (2004). (Pubitemid 41158297)
80. Miyazaki, M. Immunological abnormalities in family members of patients with IgA nephropathy. Jpn J. Med. 29, 469-477 (1990).
81. Kiryluk, K. et al. Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis. Kidney Int. 80, 79-87 (2011).
82. Gharavi, A. G. et al. Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J. Am. Soc. Nephrol. 19, 1008-1014 (2008).
83. Paterson, A. D. et al. Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36. J. Am. Soc. Nephrol. 18, 2408-2415 (2007). (Pubitemid 47203857)
84. Gharavi, A. G. et al. IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet. 26, 354-357 (2000).
85. Bisceglia, L. et al. Genetic heterogeneity in Italian families with IgA nephropathy: suggestive inkage for two novel IgA nephropathy loci. Am. J. Hum. Genet. 79, 1130-1134 (2006). (Pubitemid 44853485)
86. Karnib, H. H. et al. Characterization of a large Lebanese family segregating IgA nephropathy. Nephrol. Dial. Transplant 22, 772-777 (2007). (Pubitemid 46351684)
87. Hsu, S. I. et al. Genome-wide linkage scan for familial IgA nephropathy among southeast Asian Chinese: evidence for a suggestive novel susceptibility locus on chromosome 8p23 [abstract]. American Society of Nephrology Renal Week F-PO1405 (2009).
88. Feehally, J. et al. HLA has strongest association with IgA nephropathy in genome-wide analysis. J. Am. Soc. Nephrol. 21, 1791-1797 (2010).
89. Gharavi, A. G. et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet 43, 321-327 (2011).
90. Kiryluk, K. et al. Genetic studies of IgA nephropathy: past, present, and future. Pediatr. Nephrol. 25, 2257-2268 (2010).
91. Lai, K. N. et al. Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-β synthesis and signal transduction in human mesangial cells via the renin-angiotensin system. J. Am. Soc. Nephrol. 14, 3127-3137 (2003). (Pubitemid 37509290)
92. van Kooten, C., Daha, M. R. & Van Es, L. A. Tubular epithelial cells: A critical cell type in the regulation of renal inflammatory processes. Exp. Nephrol. 7, 429-437 (1999). (Pubitemid 29517353)
93. Lai, K. N., Leung, J. C., Chan, L. Y., Guo, H. & Tang, S. C. Interaction between proximal tubular epithelial cells and infiltrating monocytes/T cells in the proteinuric state. Kidney Int 71, 526-538 (2007). (Pubitemid 46402860)
94. Tang, S. et al. Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J. Clin. Invest. 111, 515-527 (2003). (Pubitemid 36228009)
95. Lai, K. N. et al. Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy. Nephrol. Dial. Transplant 24, 62-72 (2009).
96. Coppo, R. et al. Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocyte. Kidney Int 77, 417-427 (2010).
97. Lai, K. N. et al. Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1. Kidney Int 66, 1403-1416 (2004). (Pubitemid 39298372)
98. Wang, L., Flannery, P. J. & Spurney, R. F Characterization of angiotensin II-receptor subtypes in podocytes. J. Lab. Clin. Med. 142, 313-321 (2003). (Pubitemid 37487401)
99. Chan, L. Y., Leung, J. C., Tang, S. C., Choy, C. B. & Lai, K. N. Tubular expression of angiotensin I receptors and their regulation in IgA nephropathy. J. Am. Soc. Nephrol. 16, 2306-2317 (2005). (Pubitemid 41725048)
100. Chansel, D. et al. Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells. Am. J. Physiol. 266, F384-F393 (1994).
101. Makita, N., Iwai, N., Inagami, T. & Badr, K. F Two distinct pathways in the down-regulation of type-1 angiotension II receptor gene in rat glomerular mesangial cells. Biochem. Biophys. Res. Commun. 185, 142-146 (1992).
102. Wagner, J., Gehlen, F., Ciechanowicz, A. & Ritz, E. Angiotensin II receptor type 1 gene expression in human glomerulonephritis and diabetes mellitus. J. Am. Soc. Nephrol. 10, 545-551 (1999). (Pubitemid 29117636)
103. Leung, J. C. et al. Oxidative damages in tubular epithelial cells in IgA nephropathy: role of crosstalk between angiotensin II and aldosterone. J. Transl. Med. 9, 169 (2011).